oct 17, 2014 - FDA approved new labeling for Embeda (morphine sulfate and naltrexone hydrochloride), an extended-release (ER) opioid analgesic to treat pain severe enough to require daily, around-the- clock, long-term opioid treatment and for which alternative treatment options are inadequate.
Added to timeline:
Date:
oct 17, 2014
Now
~ 11 years ago